TLR9 and glioblastoma: As shown in Table 3, the multivariate analysis revealed that the expression levels of TLR9 protein level was a significant prognostic factor in GBM patients, independent of the conventional clinical variables (hazard ratio [HR], 3.205; 95% confidence interval [CI], 1.152-8.920; p = 0.026).